Ready to Revolutionize Drug Development? Join us for #CERTAINTY Europe on 29-30 October in Mainz, Germany! This exclusive client event is designed for trailblazers in biosimulation, clinical pharmacology, AI, and regulatory science. Be at the forefront of drug development—connect with peers, gain invaluable insights, and drive the conversation forward. https://lnkd.in/ejDR83h5 🔍Engage in discussions on critical topics such as: - The Impact of MIDD in Decision-Making - Generative AI in Non-Clinical Development - Accelerating Insights with Digital Data Flow 🚀Let's achieve greater certainty in drug development together. Register today while spots are still available: https://lnkd.in/ey8Avaub #globalCertainty #CertaintyEurope #CERTAINTY2024 #drugdevelopment
About us
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
- Website
-
https://www.certara.com
External link for Certara
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Radnor, Pennsylvania
- Type
- Public Company
- Specialties
- model-based drug discovery and development, scientific informatics, PK/PD modeling and simulation, PBPK modeling and simulation, trial design, drug development, regulatory writing, quantitative systems pharmacology, clinical pharmacology, quantitative systems toxicology, transparency and disclosure, model-based meta-analysis, regulatory strategy, regulatory publishing, market access, health economics and outcomes research, and real world evidence solutions
Locations
Employees at Certara
Updates
-
Join Steve Sibley, Vice President of Regulatory Strategy, and Rachel Bombara, Senior Manager of Regulatory Services at Certara, on September 10 at 11AM ET as they share invaluable insights and strategies to streamline your regulatory submissions. Secure your spot today and ensure your submissions are timely and successful: https://ow.ly/abPb50TeWa4 #RegulatoryAffairs #Webinar #EMA #FDA #SimultaneousSubmissions #Certara #eCTD #Pharma #Biotech
-
Meet Bill Poland, VP & Lead Scientist at Certara Drug Development Solutions! Bill is originally trained as a decision analyst and is most excited by the high-value acceleration of drug development. He has a keen interest in combining pharmacometric and probabilistic economic models to make better strategic decisions, such as program-level design and go/no-go decisions in the context of competing compounds and market dynamics. Additionally, he finds great satisfaction in seeing the drugs that his team supports through development get approved. Connect with Bill today: https://lnkd.in/dHVyDETd
-
-
🚨 Few Seats Remain! 🚨 Join us for the Simcyp Consortium Open Day In-Person Meeting – a historic first in our 25-year journey! For the first time ever, we’re inviting non-members to our “Open Day.” This is your chance to connect with industry leaders, regulatory experts, and academics, all while celebrating Simcyp’s incredible 25-year milestone. 📅 Date: September 24, 2024 📍 Location: Radisson Hotel & Conference Centre London, Heathrow To register and view the complete agenda, visit: https://lnkd.in/dTUcAmUC We hope to host you! #SimcypConsortium #OpenDay #IndustryLeaders #RegulatoryExperts #Academics #Networking #25Years #Simcyp #Certara #Pharma #Biotech #Innovation
-
-
Join us for another in-depth webinar with Prof. Johan Gabrielsson, where he will present advanced techniques for determining optimal first-in-human dose based on pharmacodynamic principles and scaled clearance methods. This session will delve into TMDD principles, target turnover and ligand-target complex kinetics. Date: 11. Sept. 2024 Time: 10:00 AM ET Register now: https://ow.ly/s9YU50TcIm3
-
-
Are You Attending ACoP15? We’re excited to be part of the 15th Annual American Conference on Pharmacometrics in Phoenix, AZ, from November 10-13, 2024! Swing by Booths #4 and #5 to gain valuable industry insights, explore our latest offerings, and discover career opportunities. We’re also presenting on several key topics: - Simcyp Designer PBPK-QSP - Model-Informed Discovery of Advanced Therapies - QSP in Late-Stage Oncology Drug Development - Modeling Drug Development in Pregnancy and Lactation - Bridging QSP and PMX in Drug Development - PMX and QSP Modeling for Prostate Cancer - Advancing to Open Models with nlmixr2 - Model-Based Meta-Analysis for Clinical Predictions Learn more about our presence at ACoP15 and register at: https://lnkd.in/e4Uq_ZWR #ACoP15 #Pharmacometics #Certara #PharmaInnovation #QSP #PMX
-
-
Get Ready for AAPS PharmSci 360! We’re excited to announce our participation in AAPS PharmSci 360, taking place October 20-23, 2024, in Salt Lake City, UT! Join us at Booth #2310 to explore the latest advancements and insights in pharmaceutical sciences. Here’s a sneak peek at what we’ll be showcasing: 🔬 Cutting-Edge Insights & Innovations: - Early Development Program Solutions - Translational Science Breakthroughs - Advanced Pharmacokinetics & Mass Spectrometry - Biomarkers and Drug-Drug Interactions (DDI) - AI/ML in Drug Discovery - Bioequivalence Innovations - Quantitative Systems Pharmacology (QSP) - Omics-Driven Drug Delivery Learn more about the event and register at: https://lnkd.in/eMXzA4ZQ See you in Salt Lake City! #AAPSPharmSci360 #PharmaceuticalScience #Innovation #AIinPharma #DrugDevelopment #Biomarkers #Pharmacokinetics #Bioequivalence #QSP #PrecisionMedicine #PharmaResearch#PrecisionMedicine #PharmaResearch
-
-
Biosimilars offer the same effectiveness as brand-name biologics but at a significantly lower cost. Thus, they have the potential to improve healthcare access. Our latest blog explores the regulatory pathways that make biosimilars possible and how they impact patient care. https://ow.ly/ALYT50T9NXP #Certara #Biosimilars #DrugDevelopment #Pharmaceuticals #Bioequivalence #Pharmacology #Pharmacokinetics #Pharmacodynamics #Biotechnology #GenericDrugs #ClinicalTrials #BiosimilarPathway #RegulatoryAffairs
-
-
📢 Exciting Announcement! On September 5, 2024, Aneesh V. Karkhanis, PhD, Research Scientist II, will be attending and presenting at a one-day DMDG meeting focused on in vivo ADME. Aneesh will be presenting a session on: “Physiologically-based Pharmacokinetic (PBPK) model of endogenous biomarkers for CYP3A induction: Our experience with 4β-hydroxycholesterol” 🗓️ Date: September 5, 2024 🕒 Time: 1:45 PM - 2:30 PM BST 📍 Location: Harrogate, UK This one-day in-person DMDG scientific meeting aims to bring together those managing and conducting in vivo studies to discuss and share information on all aspects of in vivo metabolism. For more information on this event, visit: https://lnkd.in/eF7bZ-hi
-
-
We’re happy to announce that Certara's own Demetrius Carter, SVP of Services Operations, Regulatory Services, and Sean McGee, Director of Product, will be presenting at #RAPSConvergence 2024. Date: Thursday, September 19, 2024 Time: 10:45 - 11:00 am PDT Session: Technology-Enabled, Human-Centered Writing: GenAI Solutions for Regulatory Writers If you're attending, don’t miss this chance to gain insights and connect with our experts. Learn more and register at: https://lnkd.in/eCmvkj2Y #RAPS2024 #RegulatoryWriting #GenAI #Certara #medicalwriting
-